Patents by Inventor David Pleynet

David Pleynet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ?-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom
    Patent number: 8119680
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Grant
    Filed: September 3, 2010
    Date of Patent: February 21, 2012
    Assignee: Neurogenetic Pharmaceuticals, Inc.
    Inventors: Soan Cheng, Daniel D Comer, Long Mao, Guity P Balow, David Pleynet
  • Compounds and uses thereof in modulating amyloid ?
    Patent number: 8017629
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Grant
    Filed: August 23, 2010
    Date of Patent: September 13, 2011
    Assignee: Neurogenetic Pharmaceuticals, Inc.
    Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
  • ALPHA-HALOKETONE DERIVATIVES OF IMIDAZOLYL-SUBSTITUTED AROMATIC COMPOUNDS AND COMPOUNDS PREPARED THEREFROM
    Publication number: 20100331551
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Application
    Filed: September 3, 2010
    Publication date: December 30, 2010
    Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
  • COMPOUNDS AND USES THEREOF IN MODULATING AMYLOID BETA
    Publication number: 20100324032
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Application
    Filed: August 23, 2010
    Publication date: December 23, 2010
    Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
  • ?-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom
    Patent number: 7799808
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Grant
    Filed: June 19, 2007
    Date of Patent: September 21, 2010
    Assignee: Neurogenetic Pharmaceuticals, Inc.
    Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
  • Compounds and uses thereof in modulating amyloid beta
    Patent number: 7781442
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: August 24, 2010
    Assignee: Neurogenetic Pharmaceuticals, Inc.
    Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
  • Compounds and Uses Thereof in Modulating Amyloid Beta
    Publication number: 20070260058
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Application
    Filed: July 17, 2007
    Publication date: November 8, 2007
    Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet
  • COMPOUNDS AND USES THEREOF IN MODULATING AMYLOID BETA
    Publication number: 20070249833
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Application
    Filed: June 19, 2007
    Publication date: October 25, 2007
    Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet
  • Compounds and uses thereof in modulating amyloid beta
    Patent number: 7244739
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: July 17, 2007
    Assignee: Torreypines Therapeutics, Inc.
    Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
  • N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
    Publication number: 20060160796
    Abstract: The present invention relates to certain compounds of Formula (I) which can be useful in the treatment of diseases, such as, cancer, metabolic disorders, Type 2 Diabetes, dyslipidemia and/or hyperchloesterolemia:
    Type: Application
    Filed: March 20, 2006
    Publication date: July 20, 2006
    Inventors: Magnus Pfahl, Catherine Tachdjian, Lyle Spruce, Hussien Al-Shamma, Mohamed Boudjelal, Andrea Fanjul, Torsten Wiemann, David Pleynet
  • Substituted heterocycles for the treatment of diabetes and other diseases
    Publication number: 20060004059
    Abstract: The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.
    Type: Application
    Filed: August 24, 2005
    Publication date: January 5, 2006
    Inventors: Magnus Pfahl, Catherine Tachdjian, Hussein Al-Shamma, Andrea Fanjul, David Pleynet, Lyle Spruce
  • RXR activating molecules
    Publication number: 20050209286
    Abstract: Disclosed are molecules that activate an RXR receptor, wherein the molecule comprises an RXR binding portion which binds the RXR receptor and comprises a side pocket contacting residue which contacts a side-pocket 1 of an RXR receptor.
    Type: Application
    Filed: March 1, 2005
    Publication date: September 22, 2005
    Inventors: Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Andrea Fanjul, David Pleynet, Lyle Spruce, Richard Fine, James Zapf, Jianhua Guo, Karine Jakubowicz-Jaillardon
  • Compounds and uses thereof in modulating amyloid beta
    Publication number: 20050070538
    Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
    Type: Application
    Filed: May 14, 2004
    Publication date: March 31, 2005
    Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet
  • Imidazolidinedione derivatives for the treatment of diabetes and other diseases
    Publication number: 20050070581
    Abstract: The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.
    Type: Application
    Filed: July 19, 2004
    Publication date: March 31, 2005
    Inventors: Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Andrea Fanjul, David Pleynet, Lyle Spruce